PT2727912T - Cristais de derivado de glicina e seu uso farmacêutico - Google Patents
Cristais de derivado de glicina e seu uso farmacêuticoInfo
- Publication number
- PT2727912T PT2727912T PT128044658T PT12804465T PT2727912T PT 2727912 T PT2727912 T PT 2727912T PT 128044658 T PT128044658 T PT 128044658T PT 12804465 T PT12804465 T PT 12804465T PT 2727912 T PT2727912 T PT 2727912T
- Authority
- PT
- Portugal
- Prior art keywords
- crystals
- pharmaceutical use
- glycine derivative
- glycine
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pulmonology (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011145446 | 2011-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2727912T true PT2727912T (pt) | 2017-07-25 |
Family
ID=47424249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT128044658T PT2727912T (pt) | 2011-06-30 | 2012-06-29 | Cristais de derivado de glicina e seu uso farmacêutico |
Country Status (13)
Country | Link |
---|---|
US (1) | US9006434B2 (pt) |
EP (1) | EP2727912B1 (pt) |
JP (1) | JP5998933B2 (pt) |
KR (1) | KR20140027944A (pt) |
CN (1) | CN103619823B (pt) |
AU (1) | AU2012276650B2 (pt) |
CA (1) | CA2837453C (pt) |
DK (1) | DK2727912T3 (pt) |
ES (1) | ES2633179T3 (pt) |
PL (1) | PL2727912T3 (pt) |
PT (1) | PT2727912T (pt) |
UA (1) | UA111213C2 (pt) |
WO (1) | WO2013002364A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPWO2014051056A1 (ja) * | 2012-09-28 | 2016-08-22 | 東レ株式会社 | グリシン誘導体の結晶及びその医薬用途 |
JP7233829B2 (ja) | 2016-12-27 | 2023-03-07 | 東京製綱株式会社 | 鋼管杭式土砂崩壊予防施設及び鋼管杭式土砂崩壊予防施設の形成方法 |
JP7337724B2 (ja) | 2020-02-14 | 2023-09-04 | 大成建設株式会社 | 半地下タンク構造 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL63968A (en) | 1980-10-01 | 1985-10-31 | Glaxo Group Ltd | Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it |
NZ501589A (en) * | 1997-07-02 | 2001-10-26 | Merck & Co Inc | Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(S)-(4-fluoro)phenyl-4-(3-(5-oxo-1H,4H-1,4H-1,2,4,-triazolo)methylmorpholine |
US7566724B2 (en) * | 2004-12-24 | 2009-07-28 | Toray Industries, Inc. | Glycine derivative and use thereof |
JP5115478B2 (ja) | 2006-06-14 | 2013-01-09 | 東レ株式会社 | アレルギー性皮膚炎の治療又は予防剤 |
KR101423347B1 (ko) | 2006-06-19 | 2014-07-24 | 도레이 카부시키가이샤 | 다발성 경화증의 치료 또는 예방제 |
AU2007262083B2 (en) | 2006-06-20 | 2012-01-19 | Toray Industries, Inc. | Therapeutic or prophylactic agent for leukemia |
JPWO2014051056A1 (ja) * | 2012-09-28 | 2016-08-22 | 東レ株式会社 | グリシン誘導体の結晶及びその医薬用途 |
-
2012
- 2012-06-29 US US14/129,166 patent/US9006434B2/en not_active Expired - Fee Related
- 2012-06-29 CA CA2837453A patent/CA2837453C/en not_active Expired - Fee Related
- 2012-06-29 PL PL12804465T patent/PL2727912T3/pl unknown
- 2012-06-29 CN CN201280032431.5A patent/CN103619823B/zh not_active Expired - Fee Related
- 2012-06-29 AU AU2012276650A patent/AU2012276650B2/en not_active Ceased
- 2012-06-29 KR KR1020137025036A patent/KR20140027944A/ko active Search and Examination
- 2012-06-29 EP EP12804465.8A patent/EP2727912B1/en not_active Not-in-force
- 2012-06-29 JP JP2012530036A patent/JP5998933B2/ja not_active Expired - Fee Related
- 2012-06-29 ES ES12804465.8T patent/ES2633179T3/es active Active
- 2012-06-29 UA UAA201400835A patent/UA111213C2/uk unknown
- 2012-06-29 DK DK12804465.8T patent/DK2727912T3/en active
- 2012-06-29 PT PT128044658T patent/PT2727912T/pt unknown
- 2012-06-29 WO PCT/JP2012/066672 patent/WO2013002364A1/ja active Application Filing
Also Published As
Publication number | Publication date |
---|---|
CA2837453A1 (en) | 2013-01-03 |
JPWO2013002364A1 (ja) | 2015-02-23 |
EP2727912B1 (en) | 2017-04-19 |
JP5998933B2 (ja) | 2016-09-28 |
EP2727912A1 (en) | 2014-05-07 |
CA2837453C (en) | 2017-04-11 |
WO2013002364A1 (ja) | 2013-01-03 |
US9006434B2 (en) | 2015-04-14 |
DK2727912T3 (en) | 2017-07-17 |
CN103619823B (zh) | 2016-01-20 |
PL2727912T3 (pl) | 2017-12-29 |
ES2633179T3 (es) | 2017-09-19 |
CN103619823A (zh) | 2014-03-05 |
KR20140027944A (ko) | 2014-03-07 |
AU2012276650A1 (en) | 2014-01-23 |
EP2727912A4 (en) | 2014-12-10 |
UA111213C2 (uk) | 2016-04-11 |
US20140128605A1 (en) | 2014-05-08 |
AU2012276650B2 (en) | 2016-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258536A1 (zh) | 用於誘導組織再生的肽及其應用 | |
HK1215948A1 (zh) | 醯胺及其醫藥用途 | |
HK1199892A1 (en) | Modified mini-hepcidin peptides and methods of using thereof | |
LT2683731T (lt) | C4-monometiltriterpenoido dariniai ir jų panaudojimo būdai | |
IL228925A0 (en) | Benzothiazole compounds and their pharmaceutical use | |
EP2739144A4 (en) | COMPOUNDS AND ITS THERAPEUTIC USE | |
EP2788020A4 (en) | THERAPEUTIC USE OF ANTI-CD22 ANTIBODIES FOR THE INDUCTION OF TROGO CYTOSIS | |
EP2772483A4 (en) | 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF | |
ZA201401653B (en) | Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use | |
ZA201401071B (en) | Pyrazole compound and pharmaceutical use thereof | |
EP2718283A4 (en) | INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF | |
EP2709999A4 (en) | QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE | |
PT2727912T (pt) | Cristais de derivado de glicina e seu uso farmacêutico | |
GB201112578D0 (en) | Pharmaceutical preparation and use | |
HUE043268T2 (hu) | Pirazolvegyületek és azok gyógyászati alkalmazása | |
GB201104632D0 (en) | Use of medicament |